Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies
Pathogens · 07.11.2024 · 13 (11) · 975
DOI: 10.3390/pathogens13110975 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 07.11.2024. Verfasst von Beth Schwartz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Henry Ford St. John Hospital, Detroit, MI 48236, USA. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pseudomonas aeruginosa is causing increasing concern among clinicians due to its high mortality and resistance rates. This bacterium is responsible for various infections, especially in hospital settings, affecting some of the most vulnerable patients. Pseudomonas aeruginosa has developed resistance through multiple mechanisms, making treatment challenging. Diagnostic techniques are evolving, with rapid testing systems providing results within 4–6 h. New antimicrobial agents are continuously being developed, offering potential solutions to these complex clinical decisions. This article provides a review of the epidemiology, at-risk populations, resistance mechanisms, and diagnostic and treatment options for Pseudomonas aeruginosa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Henry Ford St. John Hospital, Detroit, MI 48236, USA.
- Thomas Mackey Center for Infectious Disease, Henry Ford St. John Hospital, Detroit, MI 48201, USA.
- Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Science, Wayne State University, Henry Ford St. John Hospital, Detroit, MI 48201, USA.
- School of Medicine, Wayne State University, Detroit, MI 48021, USA.
ORCID-Profile: Beth Schwartz, Pramodini B Kale-Pradhan, Ashish Bhargava
Zitieren
APA
Schwartz, B., Klamer, K., Zimmerman, J., Kale-Pradhan, P. B., & Bhargava, A. (2024). Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies. Pathogens, 13(11), 975. https://doi.org/10.3390/pathogens13110975
Vancouver
Schwartz B, Klamer K, Zimmerman J, Kale-Pradhan PB, Bhargava A. Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies. Pathogens. 2024;13(11):975. doi:10.3390/pathogens13110975
BibTeX
@article{Schwartz2024,
author = {Schwartz, Beth and Klamer, Katherine and Zimmerman, Justin and Kale-Pradhan, Pramodini B and Bhargava, Ashish},
title = {Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies},
journal = {Pathogens},
year = {2024},
volume = {13},
number = {11},
pages = {975},
doi = {10.3390/pathogens13110975}
}
EUVIMED